Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease

por Larouche‐Lebel, Éva, Loughran, Kerry A., Huh, Terry, Oyama, Mark A.
Publicado 2020

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease

por Huh, Terry, Larouche‐Lebel, Éva, Loughran, Kerry A., Oyama, Mark A.
Publicado 2020

Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure

por Loughran, Kerry A., Larouche‐Lebel, Éva, Huh, Terry, Testani, Jeffrey M., Rao, Veena S., Oyama, Mark A.
Publicado 2020

Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease

por Li, Qinghong, Larouche‐Lebel, Éva, Loughran, Kerry A., Huh, Terry P., Suchodolski, Jan S., Oyama, Mark A.
Publicado 2021

Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease

por Li, Qinghong, Larouche-Lebel, Éva, Loughran, Kerry A., Huh, Terry P., Suchodolski, Jan S., Oyama, Mark A.
Publicado 2021

Dysregulation of valvular interstitial cell let-7c, miR-17, miR-20a, and miR-30d in naturally occurring canine myxomatous mitral valve disease

por Yang, Vicky K., Tai, Albert K., Huh, Terry P., Meola, Dawn M., Juhr, Christine M., Robinson, Nicholas A., Hoffman, Andrew M.
Publicado 2018